Job Description
About the Role
- This is a dual-role position. The primary responsibility of this role is Pricing & Reimbursement (P&R) Lead, with an additional responsibility in New Product Planning, NPP. Candidates are expected to manage both functions concurrently and should clearly understand this dual accountability before applying.
- At AstraZeneca, we believe the only person who can limit your professional growth is yourself. With the right expertise and ambition, this role offers a unique opportunity to shape both the future of patient access and the strategic direction of AstraZeneca Korea's pipeline.
- This is a strategically critical role within the Market Access function. The role is primarily responsible for leading Pricing & Reimbursement (P&R) strategy for AstraZeneca Korea — with a particular focus on Rare Disease — while additionally supporting New Product Planning to enable accelerated market access across the broader AstraZeneca pipeline.
- The role requires close collaboration with Medical Affairs, Global Early Commercial, Global R&D, and Insights & Analytics, bridging clinical development, health economics, and commercialization planning to ensure both near-term reimbursement success and long-term pipeline readiness.
Key Responsibilities
PRIMARY ROLE: Pricing & Reimbursement Lead
P&R Strategy Development & Execution
- Lead the development and execution of comprehensive Pricing & Reimbursement strategies for AstraZeneca Korea's portfolio, with primary focus on Rare Disease assets
- Develop high-quality P&R dossiers, including health economic analyses (HEOR), budget impact models, and value demonstration frameworks aligned with Korea's reimbursement requirements
- Define and execute pricing strategies that maximize product value while ensuring sustainable, long-term market access
Payer Engagement & Negotiation
- Lead and support price negotiation strategies with Korean payer authorities including HIRA (Health Insurance Review & Assessment Service) and NHIS (National Health Insurance Service)
- Build and maintain strong, trust-based relationships with key payer stakeholders to secure optimal reimbursement outcomes
- Coordinate cross-functional teams to ensure alignment on payer engagement strategy and messaging
Policy Monitoring & Value Protection
- Proactively monitor changes in Korean pricing regulations, reimbursement policies, and healthcare policy landscape
- Develop mitigation strategies to minimize pricing erosion and protect long-term product value
- Provide actionable recommendations to Market Access Director and internal leadership on policy developments and their commercial implications
HTA Strategy & HEOR Leadership
- Lead HTA (Health Technology Assessment) strategy development, including coordination of health economic model development with internal and external HEOR experts
- Ensure P&R strategies are grounded in robust evidence and aligned with global value narratives while adapted for local Korean context
SECONDARY ROLE: New Product Planning, NPP (Early Asset Strategy)
Early Asset Strategy Representation
- Represent Corporate Strategy Early Asset on the New Product Planning Team, serving as the key interface between the Korea MC, Global Early Commercial, Global R&D, and Global SMM
- Under the direction of the New Product Planning Lead, translate integrated Early Asset strategies into operational plans with clear deliverables and timelines
Access Landscape Assessment & Pipeline Readiness
- Assess the access landscape for prioritized pipeline assets across AstraZeneca's portfolio; identify potential barriers, opportunities, and key success factors (KSFs) for accelerated market access
- Define and support market readiness initiatives, including policy shaping activities and engagement with patient advocacy groups (PAGs)
- Escalate strategic issues and recommendations to the Early Asset Lead as appropriate
Early Evidence & Commercial Integration
- Support evidence gap assessment and align access strategy with medical evidence generation plans in collaboration with Medical Affairs
- Contribute to commercial assessments — including treatment pattern studies, product profile testing, claims analysis, and patient research — to support business cases and investment decisions
- Work with Insights & Analytics teams to translate primary market research into actionable access insights
NPP Governance & Reporting
- Provide the Early Asset Lead with clear, evidence-based recommendations regarding pipeline opportunities and risks
- Maintain progress indicators and prepare regular updates for Early Asset governance forums and internal decision-making bodies
Education, Qualifications, and Experience
Essential
- Bachelor's degree in pharmacy, life sciences, health economics, or related field; advanced degree (MPH, MBA, MSc, PhD) preferred
- 5+ years of experience in Pricing & Reimbursement, Market Access, or Health Economics within the pharmaceutical or biopharmaceutical industry in Korea
- Proven track record of leading P&R dossier development and reimbursement submissions in Korea
- Strong working knowledge of Korean reimbursement processes (HIRA/NHIS), HTA frameworks, and health economic modeling
- Experience with Rare Disease products and associated premium pricing / risk-sharing scheme negotiations is highly desirable
- Ability to manage multiple concurrent workstreams across P&R and pipeline strategy functions
Preferred
- Prior exposure to New Product Planning (NPP), Early Asset Strategy, or pipeline planning within a pharmaceutical company
- Experience working in cross-functional global-local matrix environments
- Excellent communication and stakeholder management skills in both Korean and English
- Demonstrated ability to synthesize complex data into compelling, decision-ready recommendations
※ 채용 절차법에 따른 고지 사항
1. 제출한 서류는 채용 절차법에 따라, 일체 반환 의무가 없습니다.
2. 보훈대상자 및 취업보호대상자는 관련법에 의거하여 우대합니다.
3. 해외 여행 결격사유가 없어야 합니다.
4. 본 채용은 수시진행으로, 우수인력 채용 시 마감될 수 있습니다.
Date Posted
19-3월-2026
Closing Date
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.
